Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | GRM6 | O15303 | 1/20 | 0.42 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid Propyl Ester SCHEMBL27540158 | 0.98 | LMNA (0.55) | LMNAALDH1A1SMN1; SMN2GAAHPGD | |
| Toluene SCHEMBL6619657 | 0.90 | ALDH1A1 (0.55) | LMNAALDH1A1SMN1; SMN2HSD17B10RAD52 | |
| P-Xylene SCHEMBL7256576 | 0.90 | ALDH1A1 (0.52) | LMNAALDH1A1SMN1; SMN2GAAHPGD | |
| Acetic Acid Butyl Ester SCHEMBL8464588 | 0.89 | ALDH1A1 (0.64) | LMNAALDH1A1SMN1; SMN2HPGDHSD17B10 | |
| Acetic Acid Butyl Ester SCHEMBL20540736 | 0.89 | ALDH1A1 (0.64) | LMNAALDH1A1SMN1; SMN2HPGDHSD17B10 | |
| Acetic Acid Butyl Ester SCHEMBL9577010 | 0.89 | ALDH1A1 (0.64) | LMNAALDH1A1SMN1; SMN2HPGDHSD17B10 | |
| Acetic Acid Butyl Ester SCHEMBL302627 | 0.89 | ALDH1A1 (0.64) | LMNAALDH1A1SMN1; SMN2HPGDHSD17B10 | |
| Acetic Acid Pentyl Ester SCHEMBL3179656 | 0.87 | TSHR (0.57) | LMNAALDH1A1SMN1; SMN2HSD17B10TSHR | |
| Acetic Acid Butyl Ester SCHEMBL27662482 | 0.87 | ALDH1A1 (0.62) | LMNAALDH1A1SMN1; SMN2HPGDHSD17B10 | |
| Acetic Acid Butyl Ester SCHEMBL9444274 | 0.87 | ALDH1A1 (0.62) | LMNAALDH1A1SMN1; SMN2HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101874845-A | Quality control method for Chinese medicinal preparation for treating urinary infection | GUIYANG CHUNKE PHARMACEUTICAL TECHNOLOGY R & D CO LTD | 2010-11-03 | — | — | CN | claimed |
| US-8318696-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2012-11-27 | — | — | US | disclosed |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | US | disclosed |
| US-7943595-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI-AVENTIS (FR) | 2011-05-17 | — | — | US | disclosed |
| US-20060160768-A1 | Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2006-07-20 | — | — | US | disclosed |
| CN-1235914-C | Polysaccharide with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI AVENTIS (FR) | 2006-01-11 | — | — | CN | disclosed |
| CN-1200003-C | Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same | SANOFI ANVENTIS SA (FR) | 2005-05-04 | — | — | CN | disclosed |
| US-6844329-B2 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | SANOFI-SYNTHELABO (FR) | 2005-01-18 | — | — | US | disclosed |
| US-20040024197-A1 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2004-02-05 | — | — | US | disclosed |
| CN-1466594-A | Polysaccharides with antithrombotic activity comprising at least a covalent bono with biotin or a biotin derivative | ʥŵ��-�ϳ�ʵ���ҹ�˾ | 2004-01-07 | — | — | CN | disclosed |
| US-6534481-B1 | Antithrombin III binding domain consisting of a concatenation of five monosaccharides supporting a total of two carboxylic acid functions and at least four sulpho groups, said domain being directly bound at the non-reducing end by a thrombin | SANOFI-SYNTHELABO (FR) | 2003-03-18 | — | — | US | disclosed |
| CN-1228785-A | Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same | SANOFI SA (FR) | 1999-09-15 | — | — | CN | disclosed |
| EP-0514900-B1 | Inorganic-organic composite subbing layers for thermal dye transfer donor | EASTMAN KODAK CO (US) | 1995-03-29 | — | — | EP | disclosed |
| EP-0514900-A1 | Inorganic-organic composite subbing layers for thermal dye transfer donor | EASTMAN KODAK COMPANY (US) | 1992-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160768-A1 | Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SERPINC1, SELP, FGB | LMNA 1409/4885ALDH1A1 1499/4885SMN1; SMN2 4757/4885 |
| US-20040024197-A1 | Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative | SERPINC1, SELP, FGB | LMNA 1157/4885ALDH1A1 1402/4885SMN1; SMN2 4769/4885 |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SERPINC1, SELP, FGB | LMNA 1409/4885ALDH1A1 1499/4885SMN1; SMN2 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.